Endogena Therapeutics, founded by Matthias Steger MD PhD, is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs that have deteriorated due to aging and genetic diseases. EA-2351 was discovered using artificial intelligence and is being developed to treat age-related macular degeneration.
×
Endogena Therapeutics � EA-2351
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD